If Altos Labs represents the Bezos-backed assault on aging, Calico Labs (California Life Company) is Google’s moonshot equivalent. Founded in 2013 by Larry Page and Sergey Brin with initial funding exceeding $2.5 billion, Calico operates with a singular, audacious mission: to “solve death.”

Unlike narrower startups, Calico takes a big-picture approach—studying the fundamental biology of aging across species, from yeast and worms to naked mole rats and humans. Key focus areas include:

• Genomic stability — Understanding and repairing the DNA damage that accumulates over time.
• Metabolic pathways — Identifying master regulators that control lifespan across organisms.
• Protein homeostasis — Preventing the cellular “clutter” that contributes to age-related diseases.
• Cross-species insights — Translating longevity mechanisms from long-lived animals to human applications.

Calico’s secrecy is legendary—few public updates, no consumer products yet—but leaks and patents reveal progress in drug candidates for neurodegeneration, cancer, and systemic decline. Partnerships with AbbVie (over $1B committed) target age-related diseases with blockbuster potential.

For Page and Brin, Calico isn’t philanthropy. It’s existential. They view aging as humanity’s greatest challenge, and solving it as essential for long-term progress—including space colonization and AI advancement.

This comprehensive strategy resonates deeply with Suvudu’s Eternal Horizon Program™, where we apply multi-modal interventions—senolytics, epigenetic reprogramming, mitochondrial repair, and tissue renewal—to achieve systemic rejuvenation and guaranteed vitality to age 150.

Google’s founders aren’t building Calico for short-term gains. They’re engineering a world where death becomes optional.

The most powerful company on Earth is betting against mortality. The elite are thinking in centuries. Are you?

Stay locked on Star Path as we follow the biggest players redefining human limits. Which tech giant’s longevity play excites you most? Share below.